| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| HAVCR2 | LGALS9 | ENSSSCP00000026109 | ENSSSCP00000045170 | Hepatitis A virus cellular receptor 2. | Uncharacterized protein. | 0.669 |
| LGALS3 | LGALS9 | ENSSSCP00000063001 | ENSSSCP00000045170 | Galectin. | Uncharacterized protein. | 0.695 |
| LGALS3 | SLC12A2 | ENSSSCP00000063001 | ENSSSCP00000042341 | Galectin. | Solute carrier family 12 member 2. | 0.653 |
| LGALS9 | HAVCR2 | ENSSSCP00000045170 | ENSSSCP00000026109 | Uncharacterized protein. | Hepatitis A virus cellular receptor 2. | 0.669 |
| LGALS9 | LGALS3 | ENSSSCP00000045170 | ENSSSCP00000063001 | Uncharacterized protein. | Galectin. | 0.695 |
| LGALS9 | OAS1 | ENSSSCP00000045170 | ENSSSCP00000064281 | Uncharacterized protein. | 2'-5'-oligoadenylate synthase 1. | 0.576 |
| LGALS9 | PBK | ENSSSCP00000045170 | ENSSSCP00000010328 | Uncharacterized protein. | Lymphokine-activated killer T-cell-originated protein kinase isoform X1. | 0.724 |
| LGALS9 | RRAGC | ENSSSCP00000045170 | ENSSSCP00000003953 | Uncharacterized protein. | Ras related GTP binding C. | 0.714 |
| LGALS9 | RSAD2 | ENSSSCP00000045170 | ENSSSCP00000052007 | Uncharacterized protein. | Radical S-adenosyl methionine domain-containing protein 2; Interferon-inducible iron-sulfur (4FE-4S) cluster-binding antiviral protein which plays a major role in the cell antiviral state induced by type I and type II interferon. Can inhibit a wide range of viruses, including west Nile virus (WNV), dengue virus, sindbis virus, influenza A virus, sendai virus and vesicular stomatitis virus (VSV). Displays antiviral activity against influenza A virus by inhibiting the budding of the virus from the plasma membrane by disturbing the lipid rafts. This is accomplished, at least in part, thro [...] | 0.860 |
| LGALS9 | SLC12A2 | ENSSSCP00000045170 | ENSSSCP00000042341 | Uncharacterized protein. | Solute carrier family 12 member 2. | 0.622 |
| LGALS9 | SLC38A9 | ENSSSCP00000045170 | ENSSSCP00000044510 | Uncharacterized protein. | Sodium-coupled neutral amino acid transporter 9 isoform X2. | 0.710 |
| LGALS9 | SLC4A7 | ENSSSCP00000045170 | ENSSSCP00000062834 | Uncharacterized protein. | Anion exchange protein. | 0.566 |
| LGALS9 | USP18 | ENSSSCP00000045170 | ENSSSCP00000050770 | Uncharacterized protein. | USP domain-containing protein; Belongs to the peptidase C19 family. | 0.784 |
| OAS1 | LGALS9 | ENSSSCP00000064281 | ENSSSCP00000045170 | 2'-5'-oligoadenylate synthase 1. | Uncharacterized protein. | 0.576 |
| OAS1 | RSAD2 | ENSSSCP00000064281 | ENSSSCP00000052007 | 2'-5'-oligoadenylate synthase 1. | Radical S-adenosyl methionine domain-containing protein 2; Interferon-inducible iron-sulfur (4FE-4S) cluster-binding antiviral protein which plays a major role in the cell antiviral state induced by type I and type II interferon. Can inhibit a wide range of viruses, including west Nile virus (WNV), dengue virus, sindbis virus, influenza A virus, sendai virus and vesicular stomatitis virus (VSV). Displays antiviral activity against influenza A virus by inhibiting the budding of the virus from the plasma membrane by disturbing the lipid rafts. This is accomplished, at least in part, thro [...] | 0.934 |
| OAS1 | USP18 | ENSSSCP00000064281 | ENSSSCP00000050770 | 2'-5'-oligoadenylate synthase 1. | USP domain-containing protein; Belongs to the peptidase C19 family. | 0.832 |
| PBK | LGALS9 | ENSSSCP00000010328 | ENSSSCP00000045170 | Lymphokine-activated killer T-cell-originated protein kinase isoform X1. | Uncharacterized protein. | 0.724 |
| RRAGC | LGALS9 | ENSSSCP00000003953 | ENSSSCP00000045170 | Ras related GTP binding C. | Uncharacterized protein. | 0.714 |
| RRAGC | SLC38A9 | ENSSSCP00000003953 | ENSSSCP00000044510 | Ras related GTP binding C. | Sodium-coupled neutral amino acid transporter 9 isoform X2. | 0.953 |
| RSAD2 | LGALS9 | ENSSSCP00000052007 | ENSSSCP00000045170 | Radical S-adenosyl methionine domain-containing protein 2; Interferon-inducible iron-sulfur (4FE-4S) cluster-binding antiviral protein which plays a major role in the cell antiviral state induced by type I and type II interferon. Can inhibit a wide range of viruses, including west Nile virus (WNV), dengue virus, sindbis virus, influenza A virus, sendai virus and vesicular stomatitis virus (VSV). Displays antiviral activity against influenza A virus by inhibiting the budding of the virus from the plasma membrane by disturbing the lipid rafts. This is accomplished, at least in part, thro [...] | Uncharacterized protein. | 0.860 |
